贝达基林,线索利德,克洛法西明"核心"对多药耐药结核病的有效性
medRxiv : the preprint server for health sciences
|January 31, 2024
概括
使用贝达奎林,线索立德和克洛法齐明治疗耐药结核病的成功率很高. 通过额外的药物来加强这种核心治疗方案并没有显著改善结果.
科学领域:
- 传染性疾病 传染性疾病
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 多抗药性结核病 (MDR-TB) 和广泛抗药性结核病 (XDR-TB) 带来了治疗挑战,特别是对诺的耐药性.
- 对于患有MDR-TB/XDR-TB和诺基诺隆耐药性的患者,迫切需要最佳的治疗方案.
研究的目的:
- 为了比较bedaquiline,linezolid和clofazimine的核心疗程与诺诺耐药结核病患者强化疗程的有效性.
- 评估添加第三级药物或延长贝达基林持续时间对治疗成功的影响.
主要方法:
- 用一个向试验仿真来比较治疗方案.
- 包括具有诺基诺隆耐药性 (基于敏感性测试或先前暴露) 的患者.
- 应用了反向概率权重来估计治疗成功概率.
主要成果:
- 在所有评估方案中观察到高的治疗成功率 (75-84%).
- 通过额外的药物或更长的贝达基林持续时间来加强核心贝达基林-林佐利德-克洛法齐明治疗方案,并没有显著提高治疗效率.
- 与核心疗法相比,强化疗法治疗成功率在1.01至1.11之间.
结论:
- 贝达基林,线索利德和克洛法西明的核心疗法在治疗耐诺结核病方面表现出高效.
- 扩大获得这些有效药物组合的机会对于改善患者的治疗结果至关重要.
相关概念视频
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
Psychosis: Goals of Pharmacotherapy
131
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
131
Pulmonary Tuberculosis I
243
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
243
Pulmonary Tuberculosis III
332
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
332
Pulmonary Tuberculosis IV
143
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
143
Pulmonary Tuberculosis V
180
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
180


